Transdermal berberine patches represent an emerging supplement format driven by consumer interest in convenience and non-pill delivery. While ingredient-level research on berberine and chromium exists ...
Issuance of a new patent strengthens Nutriband's intellectual property protection for its AVERSA™ transdermal abuse deterrent technology in the United States. The technology potentially addresses ...
Nutriband (NTRB) files provisional patent application to enhance its AVERSA™ transdermal abuse deterrent technology being developed for patches containing opioids and stimulants with a potential for ...
This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. The AVERSA™ abuse deterrent technology is ...
AVERSA™ transdermal abuse deterrent technology is protected by a broad international intellectual property portfolio with patents issued in 46 countries including the United States, Europe, Japan, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback